Fairfield Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-30
| Closed | -$1.7K | – | 87 |
|
|
2024
Q4 | $1.7K | Hold |
30
| – | – | ﹤0.01% | 242 |
|
|
2024
Q3 | $1.55K | Hold |
30
| – | – | ﹤0.01% | 270 |
|
|
2024
Q2 | $1.25K | Buy |
+30
| New | +$1.25K | ﹤0.01% | 268 |
|
|
2023
Q3 | – | Sell |
-246
| Closed | -$15.7K | – | 303 |
|
|
2023
Q2 | $15.7K | Buy |
246
+2
| +0.8% | +$128 | 0.01% | 207 |
|
|
2023
Q1 | $16.6K | Buy |
244
+2
| +0.8% | +$136 | 0.01% | 204 |
|
|
2022
Q4 | $17.4K | Buy |
242
+2
| +0.8% | +$144 | 0.01% | 178 |
|
|
2022
Q3 | $17.1K | Buy |
240
+1
| +0.4% | +$71 | 0.01% | 181 |
|
|
2022
Q2 | $18.4K | Buy |
239
+2
| +0.8% | +$154 | 0.01% | 164 |
|
|
2022
Q1 | $17.3K | Buy |
+237
| New | +$17.3K | 0.01% | 187 |
|